DE9405878U1 - Rhenchodepressive substance - Google Patents

Rhenchodepressive substance

Info

Publication number
DE9405878U1
DE9405878U1 DE9405878U DE9405878U DE9405878U1 DE 9405878 U1 DE9405878 U1 DE 9405878U1 DE 9405878 U DE9405878 U DE 9405878U DE 9405878 U DE9405878 U DE 9405878U DE 9405878 U1 DE9405878 U1 DE 9405878U1
Authority
DE
Germany
Prior art keywords
substance
rhenchodepressive
collagen
cross
same effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9405878U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE9405878U priority Critical patent/DE9405878U1/en
Priority to DE19500548A priority patent/DE19500548A1/en
Publication of DE9405878U1 publication Critical patent/DE9405878U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

Die Rhenchopathie oder in der Umgangssprache das Schnarchen ist eine Form der Belästigung des sozialen Umfeldes, das oft zu familiären Spannungen führt.Rhenchopathy, or colloquially known as snoring, is a form of social nuisance that often leads to family tensions.

Sie oder es tritt überwiegend in Schlafrückenlage auf und ist durch Schwingungen oder Flattern des weichen Gaumensegels, auch Velum genannt, bedingt. Das Zurückfallen der Zunge, die Behinderung der Nasenatmung und andere Faktoren sind zusätzlich zu benennen. Eine besondere pathologische Form stellt die Rhenchopathie in Kombination mit der sog. Schlafapnoe dar, bei der es zum kuzfristigen Atemstillstand kommt.It occurs predominantly when sleeping on your back and is caused by vibrations or fluttering of the soft palate, also known as the velum. The tongue falling back, obstruction of nasal breathing and other factors must also be mentioned. A special pathological form is rhenchopathy in combination with so-called sleep apnea, which causes short-term respiratory arrest.

Als Gegenmaßnahmen werden v. a. eine Verhinderung der Rückenlage und in Extremfällen eine straffend Gaumensegelplastik empfohlen.The recommended countermeasures include preventing the patient from lying on their back and, in extreme cases, tightening velumplasty.

Nun ist seit einigen Jahren in der plastischen Chirurgie als Alternative zum Skalpell bei Narbenkorrekturen die gezielte Injektion von Rindercollagen bekannt, das allerdings einen hohen Grad an früher Resorption aufweist.For several years now, the targeted injection of bovine collagen has been known in plastic surgery as an alternative to the scalpel in scar correction, although this has a high degree of early resorption.

Fibrilläres Collagen besteht aus sich wiederholenden Polypeptid-Untereinheiten, genannt Tropocollagen. Diese sind zu parallelen Bündeln angeordnet und weisen eine charakteristische 64-nm lange Querstreifung zumindest bei den meisten CoUagenen auf.Fibrillar collagen consists of repeating polypeptide subunits called tropocollagen. These are arranged in parallel bundles and exhibit a characteristic 64-nm-long cross-striation, at least in most collagens.

Es besteht die Möglichkeit, über den Chemismus Collagen mit seinem ungewöhnlich hohen Anteil von Prolin- und Hydroxyprolinresten zusätzlich kovalent quer zu vernetzen.It is possible to additionally covalently cross-link collagen with its unusually high proportion of proline and hydroxyproline residues via its chemistry.

Im Falle der kosmetischen Applikation ist damit die Möglichkeit geschaffen, das Collagen nicht nur subcutan zu injizieren und die Resorption zu verzögern.In the case of cosmetic application, this creates the possibility of not only injecting the collagen subcutaneously and delaying its resorption.

Aus diesem Grundgedanken heraus entstand der erfinderische Gedanke, quervernetztes Collagen, bevorzugt mit biologischen und/oder bioaktiven Füllstoffen ins Velum zu applizieren, um auf diesem Wege eine angestrebte Velumstraffung ohne phonetische Beeinträchtigungen zu schaffen.From this basic idea arose the inventive idea of applying cross-linked collagen, preferably with biological and/or bioactive fillers, into the velum in order to achieve the desired velum tightening without phonetic impairments.

Wirktsoff und Anwendung sind in Verbindung mit der Beschreibung den Ansprüchen zu entnehmen.The active ingredient and application can be found in the claims in conjunction with the description.

Claims (2)

ANSPRÜCHEEXPECTATIONS 1. Rhenchodepressive Substanz, dadurch gekennzeichnet, daß diese als Grundgerüst ein quervernetztes Collagen oder eine bioverträgliche Substanz gleicher Wirkung aufweist und geeignet ist, Schnarchen zu unterbinden.1. Rhenchodepressive substance, characterized in that it has a cross-linked collagen or a biocompatible substance with the same effect as a basic structure and is suitable for preventing snoring. 2. Rhenchodepressive Substanz nach Anspruch 1, dadurch gekennzeichnet, daß miniaturisierte, bevorzugt bioaktive Füllkörper in das quervernetzte Collagen passiv und/oder über chemische Bindung aktiv ins Collagen oder die Substanz gleicher Wirkung eingelagert sind.2. Rhenchodepressive substance according to claim 1, characterized in that miniaturized, preferably bioactive fillers are embedded passively in the cross-linked collagen and/or actively via chemical bonding in the collagen or the substance with the same effect.
DE9405878U 1994-04-08 1994-04-08 Rhenchodepressive substance Expired - Lifetime DE9405878U1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE9405878U DE9405878U1 (en) 1994-04-08 1994-04-08 Rhenchodepressive substance
DE19500548A DE19500548A1 (en) 1994-04-08 1995-01-11 Compsn. for treating snoring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE9405878U DE9405878U1 (en) 1994-04-08 1994-04-08 Rhenchodepressive substance

Publications (1)

Publication Number Publication Date
DE9405878U1 true DE9405878U1 (en) 1995-10-12

Family

ID=6907091

Family Applications (2)

Application Number Title Priority Date Filing Date
DE9405878U Expired - Lifetime DE9405878U1 (en) 1994-04-08 1994-04-08 Rhenchodepressive substance
DE19500548A Withdrawn DE19500548A1 (en) 1994-04-08 1995-01-11 Compsn. for treating snoring

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19500548A Withdrawn DE19500548A1 (en) 1994-04-08 1995-01-11 Compsn. for treating snoring

Country Status (1)

Country Link
DE (2) DE9405878U1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008097890A2 (en) * 2007-02-02 2008-08-14 Thomas Jefferson University Method and use of a bioreplaceable tissue material implant for treating snoring

Also Published As

Publication number Publication date
DE19500548A1 (en) 1996-03-07

Similar Documents

Publication Publication Date Title
DE4412190A1 (en) Prevention of snoring
Ford et al. Clinical experience with injectable collagen for vocal fold augmentation
IL225192A (en) Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury
ATE450269T1 (en) PEPTIDE PYYÄ3-36Ü FOR THE TREATMENT OF METABOLIC DISEASES
CA2337750A1 (en) Therapeutic or cosmetic compositions containing dimeric or polymeric forms of hydroxyacids, and their therapeutic use
DE2950219A1 (en) IMPLANTED ARTIFICIAL TOOTH
DK0641223T3 (en) Biotherapeutic cell-coated microspheres
ATE435030T1 (en) HEALING OF WOUNDS OR FIBROTIC DISEASES USING AT LEAST ONE AGENT AGAINST ONE GROWTH FACTOR
EP1475056B1 (en) Implant for spreading the wings of the nose
ATE286664T1 (en) PHARMACEUTICAL OR DIETETIC COMPOSITIONS MADE OF MUSHROOMS AND USE THEREOF
MX9708800A (en) Bicyclic-aromatic compounds.
BR9707153A (en) Biaromatic compounds pharmaceutical composition cosmetic composition and use of a cosmetic composition
ES2184865T3 (en) PEPTIDE TO INHIBIT THE INCREASE IN THE LEVEL OF TRIGLICERIDS IN BLOOD EINHIBITOR TO INCREASE THE LEVEL OF TRIGLICERIDS IN BLOOD THAT UNDERSTANDS THE PEPTIDE AS ACTIVE INGREDIENT.
DE9405878U1 (en) Rhenchodepressive substance
DE69717301T2 (en) USE OF GROWTH HORMONE
DE202008005533U1 (en) Orthopedic aid with active insertion
DE69314586D1 (en) Medicament composition containing TCF-II
DE9402884U1 (en) Anti-snoring device
Verratti Neuroimmune biology of physical exercise
PT1007085E (en) USES OF GROWTH HORMONE IN COMPOSITIONS FOR THE TREATMENT OF INSULIN RESISTANCE IN THE HEART
DE202011105360U1 (en) Injury prevention clothing for humans and animals
EP4212134A1 (en) Ankle-foot orthosis
DE69219039D1 (en) Use of Felbamate in the manufacture of a medicament for the treatment of neuropsychopharmacological disorders
DE20010921U1 (en) Inflatable cushion to support knee joints and cervical spine and to fix a bath towel
Permin Oral Submucous Fibrosis: Interdependance on Pernicious Habit.